Jefferies Group LLC Iovance Biotherapeutics, Inc. Put Options Transaction History

Jefferies Group LLC

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Sep 21, 2023	SELL	$6.38 - $18.33 $1.12 Million - $3.23 Million	-176,300 Reduced 95.04%	9,200 $101,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $58,696 - $168,635	9,200 New	9,200 $102,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $3.77 Million - $4.94 Million	-185,500 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$16.33 - $33.07 $3.03 Million - $6.13 Million	185,500 New	185,500 $4.83 Million
Q2 2021 Aug 20, 2021	SELL	$16.33 - $33.07 $300 Million - $607 Million	-18,364,500 Reduced 99.0%	185,500 $4.83 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $303 Million - $613 Million	18,550,000 New	18,550,000 $4.83 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $693,750 - $907,499	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $666,645 - $1 Million	-24,500 Reduced 49.49%	25,000 $686,000
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $781,600 - $1.55 Million	40,000 Added 421.05%	49,500 $1.48 Million
Q4 2019 Feb 13, 2020	BUY	$17.95 - $29.41 $170,525 - $279,395	9,500 New	9,500 $263,000

319

243M

3.77M

1.7M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $923M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.